According to the results of 2 separate clinical trials presented at the 2018 Genitourinary Cancers Symposium, apalutamide and enzalutamide reduced the risk for metastasis and prolonged metastasis-free survival in patients with nonmetastatic castrate-resistant prostate cancer.
ATAP strongly supports a mandatory pass-through, as it would directly benefit patients by reducing their costs at the pharmacy counter.
Our news blog is comprised of several categories, including Healthy Lifestyle, Holidays, Industry News, Minute with the Board, NORM Events, NORM News, Resources, Social Media, and Tips and Tricks.
During his presentation, Cameron M. Cox, President and Chief Executive Officer, MSOC Health, Chapel Hill, NC, discussed the role of patients as customers in healthcare, the innovation of telemedicine, and the importance of online reviews.
As of December 2017, 32 states and the District of Columbia have adopted USP 797 into law, including New Hampshire. Once adopted, a state agency, which is typically the state’s Board of Pharmacy, must be appointed to oversee and enforce these standards.